Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
New York University School of Medicine |
---|---|
Information provided by: | New York University School of Medicine |
ClinicalTrials.gov Identifier: | NCT00531570 |
In the United States, ovarian cancer is the fifth most common cancer to develop in women and causes more deaths than all other gynecologic malignancies combined. Because of the difficulties in detecting early stage ovarian cancer, 75% of women continue to be diagnosed with advanced stage disease (stage III or IV).
The National Ovarian Cancer Early Detection Program (NOCEDP) as part of the National Cancer Institute's Early Detection Research Network (EDRN) is committed to the development of effective means for the accurate detection of early stage ovarian cancer.
The last decade has seen rapid technological advances in diagnostic ultrasonography with the recent development of three-dimensional imaging.
Initial studies suggest that these new technologies improve upon the diagnostic accuracy of two-dimensional transvaginal imaging in the differentiation between benign and malignant pathology.
This improved diagnostic accuracy may promote improved patient care by separating complex benign masses from ovarian cancer therefore facilitating appropriate treatment.
Condition |
---|
Ovarian Neoplasms |
Study Type: | Observational |
Study Design: | Prospective |
Official Title: | Microvascular Ultrasonographic Imaging for the Detection of Early Stage Epithelial Ovarian Carcinoma |
Ages Eligible for Study: | 21 Years and older |
Genders Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: David Fishman, M.D. | 212-263-7141 | david.fishman@med.nyu.edu |
Contact: Louise Lynch, R.N. | 212-731-5405 | louise.lynch@nyumc.org |
United States, New York | |
NYU Cancer Institute | Recruiting |
New York, New York, United States, 10016 | |
Contact: David Fishman, M.D. 212-263-7141 david.fishman@med.nyu.edu | |
Contact: Louise Lynch, R.N. 212-731-5405 louise.lynch@nyumc.org | |
Principal Investigator: David Fishman, M.D. |
Principal Investigator: | David Fishman, M.D. | New York University School of Medicine |
Responsible Party: | New York University School of Medicine ( David Fishman, M.D. ) |
Study ID Numbers: | NYU 04-31 H11941 |
Study First Received: | September 18, 2007 |
Last Updated: | May 21, 2008 |
ClinicalTrials.gov Identifier: | NCT00531570 |
Health Authority: | United States: Institutional Review Board |
Women with ultrasound defined complex pelvic masses |
Genital Diseases, Female Ovarian cancer Ovarian Neoplasms Gonadal Disorders Genital Neoplasms, Female Endocrine System Diseases |
Urogenital Neoplasms Endocrinopathy Ovarian Diseases Ovarian epithelial cancer Endocrine Gland Neoplasms Carcinoma |
Neoplasms Neoplasms by Site Adnexal Diseases |